Encoded Makes Chief Regulatory, People & Culture Officer Appointments

Encoded Therapeutics added two people to its C-suite this week. The South San Francisco-based company named Nancy Boman as its chief regulatory officer and Monique Bobadilla as its chief people and culture officer.

Encoded, which raised $104 million in June, aims to develop gene therapies to treat diseases the technique currently can’t address. Its lead drug candidate is an investigational treatment for a rare form of epilepsy called Dravet syndrome.

Boman was most recently chief regulatory officer at AveXis, where she led the company’s application for Zolgensma, the spinal muscular atrophy gene therapy that prompted the biotech’s acquisition last year by Novartis (NYSE: [[ticker:NVS]]) for $8.7 billion. Previously she held roles at Alder BioPharmaceuticals (now part of Lundbeck), Acucela, Genentech, and Amgen (NASDAQ: [[ticker:AMGN]]).

Bobadilla previously held human resources-related roles at Genentech, Biogen (NASDAQ: [[ticker:BIIB]](), Digirad Imaging Systems, and Edwards Lifesciences (NYSE: [[ticker:EW]]).

Author: Sarah de Crescenzo

Sarah is Xconomy's San Diego-based editor. Prior to joining the team in 2018, she wrote about startups, tech and finance at the San Diego Business Journal. Her decade of full-time news experience includes coverage of subjects including campaign finance, crime and courts as a reporter and editor at outlets throughout California, including the Orange County Register. She earned a bachelor's degree in English Literature at UC San Diego, where she wrote for the student newspaper and played collegiate lacrosse. In 2019, she earned an MBA at UC Irvine.